CA2233135A1 - Compositions de phospholipides stabilisees - Google Patents

Compositions de phospholipides stabilisees Download PDF

Info

Publication number
CA2233135A1
CA2233135A1 CA002233135A CA2233135A CA2233135A1 CA 2233135 A1 CA2233135 A1 CA 2233135A1 CA 002233135 A CA002233135 A CA 002233135A CA 2233135 A CA2233135 A CA 2233135A CA 2233135 A1 CA2233135 A1 CA 2233135A1
Authority
CA
Canada
Prior art keywords
composition
contrast
nmt
buffer system
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002233135A
Other languages
English (en)
Inventor
Kari Dyvik
Harald Dugstad
Roald Skurtveit
Jo Klaveness
Jonny Ostensen
Kiyoto Yachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
GE Healthcare AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2233135A1 publication Critical patent/CA2233135A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)

Abstract

On a amélioré la stabilité de compositions de phospholipides par l'addition d'un système de tampon comprenant de l'ammoniaque ou une amine hydrosoluble d'un pH, à 15 ·C, inférieur ou égal à 9,5.
CA002233135A 1995-09-27 1996-09-25 Compositions de phospholipides stabilisees Abandoned CA2233135A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9519654.9 1995-09-27
GBGB9519654.9A GB9519654D0 (en) 1995-09-27 1995-09-27 Stabilised phospholipid compositions

Publications (1)

Publication Number Publication Date
CA2233135A1 true CA2233135A1 (fr) 1997-04-03

Family

ID=10781317

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002233135A Abandoned CA2233135A1 (fr) 1995-09-27 1996-09-25 Compositions de phospholipides stabilisees

Country Status (7)

Country Link
EP (1) EP0857070A2 (fr)
JP (1) JP2000515487A (fr)
CN (1) CN1202830A (fr)
CA (1) CA2233135A1 (fr)
GB (1) GB9519654D0 (fr)
NO (1) NO981340D0 (fr)
WO (1) WO1997011683A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4752987B2 (ja) * 2000-10-12 2011-08-17 ライオン株式会社 外用剤組成物
WO2007129311A2 (fr) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nanoparticules avec agents de contraste pour systeme de delivrance diagnostique pour radiographie et tomodensitometrie
JP5355588B2 (ja) * 2007-12-20 2013-11-27 ノバルティス アーゲー コンタクトレンズを製造する方法
JP5299449B2 (ja) * 2011-02-23 2013-09-25 ライオン株式会社 外用剤組成物
CN104561156B (zh) * 2013-10-28 2020-07-07 丰益(上海)生物技术研发中心有限公司 制备饱和型磷脂的方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
ZA902710B (en) * 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
DE69527194T2 (de) * 1994-03-28 2003-02-06 Nycomed Imaging As Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel

Also Published As

Publication number Publication date
WO1997011683A2 (fr) 1997-04-03
GB9519654D0 (en) 1995-11-29
WO1997011683A3 (fr) 1997-06-26
JP2000515487A (ja) 2000-11-21
EP0857070A2 (fr) 1998-08-12
CN1202830A (zh) 1998-12-23
NO981340L (no) 1998-03-24
NO981340D0 (no) 1998-03-24

Similar Documents

Publication Publication Date Title
EP0752889B1 (fr) Liposomes contenant un agent de contraste au rayons-x ou au ultrason
US4544545A (en) Liposomes containing modified cholesterol for organ targeting
KR100399712B1 (ko) 혈액-푸울영상화조성물사용및방법
Grant et al. A liposomal MRI contrast agent: Phosphatid ylethanolamine‐DTPA
CA2103462C (fr) Agent de contraste pour rayons x
JP4317270B2 (ja) 投与性組成物および磁気共鳴画像法
EP0607401B1 (fr) Particules pour imagerie rmn et procede de fabrication
CA2056371C (fr) Suspensions de microbulles stables injectables dans des organismes vivants
US5997898A (en) Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
EP0871431B1 (fr) Emulsion aqueuse hepatocyto-selective
WO1996031196A1 (fr) Compositions nouvelles de lipides et de materiaux de stabilisation
JP2003530362A (ja) 診断剤をターゲッティングするための脂質ベースの系
JP3759765B2 (ja) リポソーム
US6645463B1 (en) Blood-pool selective carrier for lipophilic imaging agents
HUT75465A (en) Process for enchancing the stability of liposomal suspensions containing hydrophilic active agents
US20020039556A1 (en) Stabilised phospholipid compositions
CA2233135A1 (fr) Compositions de phospholipides stabilisees
Cevc Drug-carrier and stability properties of the long-lived lipid vesicles. Cryptosomes, in vitro and in vivo
JPWO2008081686A1 (ja) コレステロール誘導体、リポソーム、リポソームの形成方法およびｘ線用造影剤
CA2286138A1 (fr) Vehicule du pool sanguin pour agents d'imagerie lipophiles
US5654452A (en) Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions

Legal Events

Date Code Title Description
FZDE Dead